HTG Molecular Diagnostics, Inc.(Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the issuance of Japan Patent Number 6290202 for “Nuclease Protection Methods for Detection of Nucleotide Variants.”
The patented technology involves a nuclease-protection method using wild‑type and variant probes competing for binding to a target nucleic acid molecule, such as messenger RNA, to detect the presence, if any, of a variant nucleotide in the target. The patent, which provides protection until June 2033, is part of a family of patents and patent applications claiming this method, including U.S. patent no. 9,765,385 issued on September 19, 2017.
